Skip to main content


In the biotechnology sector HELM has three participations in Germany and is additionally engaged in the development of transdermal active ingredient patches in Argentina. Through a participation in Switzerland HELM is active in the demanding market for chronic obstructive pulmonary diseases (COPD) treatment.

HELM holds numerous investments in production companies in order to strengthen the marketing activities:

  • Richter-Helm BioLogics, Germany

Moreover, HELM has participations in these development companies:

  • Phargentis, Switzerland
  • Amarin Technologies S. A., Argentina